International Journal of Cancer Management

Published by: Kowsar

A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women

Cingeetham Vinod 1 , Akka Jyothy 1 , Malladi Vijay kumar 2 , Ramaiyer Raghu Raman 2 , Pratibha Nallari 3 and Ananthapur Venkateshwari 1 , *
Authors Information
1 Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad, India
2 MNJ Institute of Oncology and Regional Cancer Centre, University, Hyderabad, India
3 Department of Genetics, Osmania University, Hyderabad, India
Article information
  • Iranian Journal of Cancer Prevention: August 28, 2015, 8 (4); e3434
  • Published Online: August 24, 2015
  • Article Type: Research Article
  • Received: July 6, 2015
  • Accepted: July 11, 2015
  • DOI: 10.17795/ijcp-3434

To Cite: Vinod C, Jyothy A, Vijay kumar M, Raman R R, Nallari P, et al. A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women, Int J Cancer Manag. 2015 ; 8(4):e3434. doi: 10.17795/ijcp-3434.

Abstract
Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5)-86[DOI][PubMed]
  • 2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646-74[DOI][PubMed]
  • 3. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol. 1992; 4(3): 314-20[PubMed]
  • 4. Wang R, Lu M, Zhang J, Chen S, Luo X, Qin Y, et al. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res. 2011; 30: 62[DOI][PubMed]
  • 5. Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res. 1999; 19(7): 697-703[DOI][PubMed]
  • 6. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24(1): 1-8[PubMed]
  • 7. Lahiri DK, Nurnberger JJ. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991; 19(19): 5444[PubMed]
  • 8. Abdolrahim-Zadeh H, Hakkakian N, Asadollahi R, Gharesifard B, Sarvari J, Kamali-Sarvestani E, et al. Interleukin-10 Promoter Polymorphisms and Breast Cancer Risk in Iranian Women. IJI. 2005; 2(3): 158-65
  • 9. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996; 77(11): 2318-24[DOI][PubMed]
  • 10. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004; 4(9): 665-76[DOI][PubMed]
  • 11. Parkin DM. International variation. Oncogene. 2004; 23(38): 6329-40[DOI][PubMed]
  • 12. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1999; 1(1): 14-7[PubMed]
  • 13. Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006; 25(43): 5898-905[DOI][PubMed]
  • 14. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics. 1997; 46(2): 120-8[PubMed]
  • 15. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol. 1995; 154(3): 1280-6[PubMed]
  • 16. Giordani L, Bruzzi P, Lasalandra C, Quaranta M, Schittulli F, Della Ragione F, et al. Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem. 2003; 49(10): 1664-7[PubMed]
  • 17. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Koppel H, et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2005; 90(2): 113-5[DOI][PubMed]
  • 18. Howell WM, Rose-Zerilli MJ. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer. 2006; 5(2): 143-9[DOI][PubMed]
  • 19. Smith KC, Bateman AC, Fussell HM, Howell WM. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet. 2004; 31(4): 167-73[DOI][PubMed]
  • 20. Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer. 2006; 6: 188[DOI][PubMed]
  • 21. Kong F, Liu J, Liu Y, Song B, Wang H, Liu W. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res. 2010; 29: 72[DOI][PubMed]
  • 22. Kang X, Kim HJ, Ramirez M, Salameh S, Ma X. The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol. 2010; 184(7): 3718-24[DOI][PubMed]
  • 23. Ursing BM, van Enckevort FH, Leunissen JA, Siezen RJ. EXProt--a database for EXPerimentally verified Protein functions. In Silico Biol. 2002; 2(1): 1-4[PubMed]
  • 24. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005; 78(5): 1043-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments